C.R. Bard Pays $48 Million To Settle Brachytherapy False Claims Act Allegations
This article was originally published in The Gray Sheet
Executive Summary
The settlement addresses allegations by the Justice Department that the company provided kickbacks to Medicare customers and physicians from 1998 to 2006 to purchase brachytherapy seeds used to treat prostate cancer.
You may also be interested in...
Abbott Settlement With DOJ Highlights Feds’ Anti-Fraud Efforts
Abbott will pay $5.47 million to resolve allegations that it paid physicians for teaching assignments, speaking engagements and conferences with the expectation that they would in return facilitate product purchases at their hospitals.
Abbott Settlement With DOJ Highlights Feds’ Anti-Fraud Efforts
Abbott will pay $5.47 million to resolve allegations that it paid physicians for teaching assignments, speaking engagements and conferences with the expectation that they would in return facilitate product purchases at their hospitals.
News In Brief
Consensus document issued on transcatheter heart valves. Boston Scientific launches Asia-Pacific organization. More news briefs.